Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Ark Therapeutics
Ark Therapeutics
Activities:
Research & Development
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Ark Therapeutics makes a promotion
David Venables will become ceo on 1 August
Pharmaceutical
New head of business development for Ark
Kassim Kolia will build firm’s manufacturing services business at Finland facility
Research & Development
David Venables joins Ark Therapeutics
As executive director of manufacturing services
Manufacturing
Ark agrees manufacturing deal with Glasgow University
To support development of gene-therapy programme for treating vein graft failure
Manufacturing
Ark and PsiOxus sign manufacturing agreement
To support the development of colorectal cancer treatment
Research & Development
Ark-led consortium wins €5.3m grant
To fund project that combines adenoviral-delivered gene therapeutics and stem cell therapy
Research & Development
Ark wins funding to progress lentiviral technology
Grants awarded by agencies in Finland
Subscribe now